PURPOSE: To comparatively investigate changes in epithelial thickness between myopic femtosecond laser–assisted LASIK (FS-LASIK) and small incision lenticule extraction (SMILE). METHODS: This study compared the topographic epithelial thickness changes in 175 myopic eyes undergoing FS-LASIK (62 eyes) or SMILE (113 eyes). Epithelial thickness was obtained using spectral-domain optical coherence tomography before surgery and 1 and 3 months after surgery. Topographic epithelial thickness obtained by automatic algorithm and thickness variability (standard deviation over 17 imaged areas) was compared between two groups. Postoperative epithelial thickness changes were correlated with treatment parameters. RESULTS: For FS-LASIK, the mean epithelial thickness of the center zone (2 mm in diameter), paracenter (2 to 5 mm), and mid-periphery (5 to 6 mm) increased by 3.4, 4.3, and 2.1 µ m, respectively, at 1 month and by 4.4, 5.1, and 2.9 µ m, respectively, at 3 months. There was an increase of 2.5, 3.9, and 4.5 µ m, respectively, at 1 month and 3.0, 4.2, and 4.9 µ m, respectively, at 3 months following SMILE. The epithelial thickness did not change between 1 and 3 months postoperatively following SMILE, whereas it increased further after FS-LASIK. A larger increase of epithelial thickness was observed in the central zone at 3 months following FS-LASIK than SMILE, whereas the opposite was observed in the mid-periphery. The topographic thickness variability was greater after FS-LASIK than SMILE. Corneal epithelial thickening was proportional to the amount of myopia correction after both procedures. CONCLUSIONS: Topographic epithelial remodeling patterns differ following FS-LASIK or SMILE. Epithelial remodeling appears to stabilize more rapidly following SMILE than FS-LASIK.
[
J Refract Surg.
2017;33(4):250–256.]
To investigate topographic changes in corneal epithelial thickness (CET) and stromal thickness following orthokeratology (OK) and to determine associated factors affecting refractive changes. This study investigated the topographic changes in CET and stromal thickness in 60 myopic eyes that were fitted with OK lenses. CET and stromal thickness were obtained using spectral-domain optical coherence tomography (OCT) before and after OK lens wear. Changes in refractive error and corneal topography data were obtained. The correlation between refractive change and corneal thickness change, and various refractive, lens, and topographic parameters were analyzed using simple regression analysis. Mean refractive error changed by 1.75 ± 0.79 diopters (D). The mean CET of the center zone (2 mm in diameter), paracenter (2 to 5 mm annular ring: 1 to 2.5 mm from center), and mid-periphery (5 to 6 mm annular ring: 2.5 to 3 mm from center) changed by -8.4, -1.4, and +2.7 μm, respectively, after OK lens wear. There was an increase of 2.0, 3.3, and 3.9 μm, respectively, in the center, paracenter, and mid-periphery of the stroma. A larger refractive correction was associated with a flatter base curve of the lens, larger decrease in the central epithelium, and smaller treatment diameter in corneal topography. OK lenses caused the central corneal epithelium to thin while the mid-peripheral epithelium and stroma became thicker. Refractive changes during OK are associated with changes in central epithelial thickness, while stromal changes did not contribute significantly.
Purpose: Fibroblast activation may play an important role in pterygium progression. Synthetic peroxisome proliferator-activated receptor γ (PPAR-γ) ligands have been shown to be effective antifibrotic agents against transforming growth factor β1 (TGF-β1) induced fibrosis in several tissues. We aimed to investigate the antifibrotic effects of the PPAR-γ ligand rosiglitazone in pterygium fibroblasts and the underlying mechanisms. Methods: Profibrotic activation was induced by TGF-β1 in primary cultured human pterygium fibroblasts and the effect of rosiglitazone treatment on α-smooth muscle actin (α-SMA), and extra cellular matrix proteins synthesis was detected by western blotting, real-time PCR, immunostaining, and flow cytometry. Pharmaceutical inhibition of PPAR-γ receptor was used to determine the dependency or otherwise of rosiglitazone's action on PPAR-γ signaling. Major signaling pathways downstream of TGF-β1 were investigated by western blotting to assess their possible association with rosiglitazone's effect. Cell viability and apoptosis were investigated to assess drug-induced cytotoxicity, and the effect of rosiglitazone treatment on cell migration was further determined. Results: α-SMA and fibronectin synthesis induced by TGF-β1 were suppressed by rosiglitazone treatment in a dose-dependent manner. Rosiglitazone also inhibited intrinsic TGF-β1 expression. Smad2/3, ERK1/2, and P38 pathways were activated in response to TGF-β1. Rosiglitazone suppressed TGF-β1-induced P38 MAPK activation, while ERK1/2 and Smad2/3 signaling remained unaffected. The observed antifibrotic effect of rosiglitazone was not affected by the PPAR-γ antagonist GW9662, indicating it is not PPAR-γ dependent. Rosiglitazone also inhibited the proliferation and migration of pterygium fibroblasts. Conclusions: Rosiglitazone suppresses TGF-β1-induced myofibroblast activation and extra cellular matrix synthesis in pterygium fibroblasts at least partly through the modulation of the p38 MAPK pathway.
To assess the nationwide rate of acute postoperative endophthalmitis (APE) after cataract extraction in Korea and to evaluate potential risk factors thereof. Nationwide insurance claims data from July 2014 to June 2017 were reviewed. All patients with phacoemulsification or extracapsular/intracapsular cataract extraction were included. Exclusion criteria were combined glaucoma surgery or total vitrectomy or when the patient had a history of intraocular foreign body. In total, 1505103 cases (982203 patients) were included. APE developed in 953 cases (938 patients) with an overall incidence of 0.063%. After adjusting for possible confounding factors, male sex [odds ratio (OR) 1.42; 95% confidence interval (CI) 1.25-1.61; p<0.001], primary clinical setting, operations performed in non-major cities, usage of sutures (OR 2.82; 95% CI 2.13-3.74; p<0.001), anterior vitrectomy (OR 8.71; 95% CI 6.71-11.32; p<0.001), aphakic cataract surgery (OR 1.52; 95% CI 1.03-2.22; p=0.033), hypertension (OR 1.40; 95% CI 1.18-1.66; p<0.001), diabetes (OR 1.59; 95% CI 1.31-1.93; p<0.001), and chronic renal failure (OR 1.28; 95% CI 1.01-1.62; p=0.039) were found to be related to APE development. The incidence of APE after cataract extraction was consistent with reports from other studies. Additional research is needed to determine the relationship of newly found risk factors, such as hypertension, primary clinical setting, chronic renal failure, and usage of suturing, with APE development.
2 January 2019 in Investigative Ophthalmology & Visual Science
Purpose: Profibrotic activation is essential for pterygium development. In this study, we investigated the role of the mechanistic target of rapamycin (mTOR) in regulating TGF-β1-induced myofibroblastic responses in human pterygium fibroblasts (HPFs) and elucidated the relative contributions of mTOR signaling components. Methods: HPFs were pretreated with the mTOR inhibitors rapamycin and Torin2, and TGF-β1-induced expression of profibrotic markers, including α-smooth muscle actin (α-SMA) and fibronectin, was evaluated. RNA interference-based approaches targeting raptor and rictor, regulatory subunits of mTOR complex 1 (mTORC1) and 2 (mTORC2), respectively, were used to determine the impact of each mTOR complex on HPFs. The contractile phenotype of HPFs was assessed by a collagen gel contraction assay. Results: The mTOR active-site inhibitor Torin2, which suppresses both mTORC1 and mTORC2 activity in HPFs, inhibited TGF-β1-induced expression of α-SMA and fibronectin. The allosteric inhibitor rapamycin only partially suppressed mTORC1 activity and exhibited a minimal effect on the induction of profibrotic markers. The induction of α-SMA and fibronectin in HPFs was abrogated by RNA interference-mediated knockdown of rictor but was only moderately affected by raptor knockdown. Akt inhibition mimicked the effect of Torin2 and rictor knockdown on myofibroblast differentiation of HPFs. mTOR inhibition potently reduced the contractile ability of HPFs in collagen gel contraction assays. Conclusions: This study found that mTOR signaling promoted profibrotic activation of HPFs and confirmed the importance of the mTORC2-Akt axis in TGF-β1-induced myofibroblast differentiation. Therefore, our study may open up new avenues for the development of novel therapeutic strategies involving targeting of mTOR signaling to treat pterygium.